Headlands Technologies »

Ligand Pharmaceuticals In shares owned by Headlands Technologies

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $69k 964 71.42
2023-09-30 $82k 1.4k 59.92
2023-06-30 $116k 1.6k 72.10

More positions owned by Headlands Technologies

Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Pepsi (PEP)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Workday Cl A (WDAY)
Citigroup Com New (C)
Icici Bank Adr (IBN)
Synopsys (SNPS)
Meta Platforms Cl A (META)

View all positions for Headlands Technologies

Top funds holding Ligand Pharmaceuticals In

Vanguard Group
Henderson Group
Dimensional Fund Advisors
St. Denis J. Villere & Co
Pacer Advisors
Standard Life Aberdeen
Rice Hall James & Associates
Chicago Capital
Impax Asset Management Group
William Blair Investment Management
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of New York Mellon
Man Group
Kornitzer Capital Management

View all funds holding Ligand Pharmaceuticals In